23 September, 2014 by The TZ Newswire Staff Comments Off on Market Snapshot: U.S. stocks: Futures dip on mixed bag of global data
Market Snapshot: U.S. stocks: Futures dip on mixed bag of global data
Stock futures track global markets lower, as weak European data overshadow upbeat Chinese readings and as investors remain cautious after the previous day’s selling on Wall Street.
read more
23 September, 2014 by The TZ Newswire Staff Comments Off on Asia Markets: Hong Kong stocks end lower despite China data surprise
Asia Markets: Hong Kong stocks end lower despite China data surprise
Hong Kong stocks close lower Tuesday, hurt mainly by casino stocks and despite an unexpected rise of a closely watched gauge of Chinese manufacturing activity.
read more
23 September, 2014 by The TZ Newswire Staff Comments Off on Tax Guy: Earn tax-free income in a Roth IRA for over 50 years
Tax Guy: Earn tax-free income in a Roth IRA for over 50 years
This is a smart idea if you have IRA money you won’t be needing for retirement, writes Bill Bischoff.
read more
23 September, 2014 by The TZ Newswire Staff Comments Off on Procrastinators may get best Thanksgiving airfare
Procrastinators may get best Thanksgiving airfare
Why you should wait to buy plane tickets for Thanksgiving.
<
23 September, 2014 by The TZ Newswire Staff Comments Off on Jeanette Pavini’s Buyer Beware: Organic chemistry: Should you do a CSA ‘farm share’?
Jeanette Pavini’s Buyer Beware: Organic chemistry: Should you do a CSA ‘farm share’?
CSA programs, also known as ‘farm shares,’ can connect you with a steady supply of local, organic produce—but don’t expect limitless food options.
read more
23 September, 2014 by The TZ Newswire Staff Comments Off on David Weidner’s Writing on the Wall: This is where the Alibaba IPO went wrong
David Weidner’s Writing on the Wall: This is where the Alibaba IPO went wrong
Founder Jack Ma and his bankers seem to have misjudged demand, writes David Weidner.
read more
23 September, 2014 by The TZ Newswire Staff Comments Off on Drug company shares pummeled by US tax moves
Drug company shares pummeled by US tax moves
Shares in drugmakers AstraZeneca and Shire both fell more than 5 percent after the U.S. Treasury took steps to curb “inversion” deals.